References
- Achour, B., Barber, J., & Rostami-Hodjegan, A. (2014). Expression of hepatic drug metabolizing cytochrome p450 enzymes and their intercorrelations: A meta-analysis. Drug Metabolism and Disposition, 42(8), 1349–1356. https://doi.org/https://doi.org/10.1124/dmd.114.058834
- Aiello, S., Wells, G., Stone, E. L., Kadri, H., Bazzi, R., Bell, D. R., Stevens, M. F. G., Matthews, C. S., Bradshaw, T. D., & Westwell, A. D. (2008). Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648). Journal of Medicinal Chemistry, 51(16), 5135–5139. https://doi.org/https://doi.org/10.1021/jm800418z
- Can-Eke, B., Puskullu, M. O., Buyukbingol, E., & Iscan, M. (1998). A study on the antioxidant capacities of some benzimidazoles in rat tissues. Chemico-Biological Interactions, 113(1), 65–77. https://doi.org/https://doi.org/10.1016/S0009-2797(98)00020-9
- Chhonker, Y. S., Veenu, B., Hasim, S. R., Kaushik, N., Kumar, D., & Kumar, P. (2009). Synthesis and pharmacological evaluation of some new 2-phenyl benzimidazoles derivatives and their Schiff's bases. E-Journal of Chemistry, 6(S1), S342–S346. https://doi.org/https://doi.org/10.1155/2009/604203
- Chuiguk, V., & Fedotov, K. (1981). Pyrido (1, 2‐a) benzimidazoles and pyrido (1, 2‐a)‐and‐(2, 1‐ b) benzazolium salts from diheterylmethanes and 1, 3‐diketones. Chemischer Informationsdienst, 12(30), 197-202. https://doi.org/https://doi.org/10.1002/chin.198130218
- Cressier, D., Prouillac, C., Hernandez, P., Amourette, C., Diserbo, M., Lion, C., & Rima, G. (2009). Synthesis, antioxidant properties and radioprotective effects of new benzothiazoles and thiadiazoles. Bioorganic & Medicinal Chemistry, 17(14), 5275–5284. https://doi.org/https://doi.org/10.1016/j.bmc.2009.05.039
- Dang, T. T., Soulé, J.-F., Doucet, H., Benmensour, M. A., Boucekkine, A., Colombo, A., Dragonetti, C., Righetto, S., Jacquemin, D., Boixel, J., & Guerchais, V. (2016). Asymmetrical 1, 3‐bis (heteroazolyl) benzene platinum complexes with tunable second‐order non‐linear optical properties. European Journal of Inorganic Chemistry, 2016(29), 4774–4782. https://doi.org/https://doi.org/10.1002/ejic.201600675
- Dauer, D. R., Flügge, M., Herbst-Irmer, R., & Stalke, D. (2016). Group 13 metal complexes containing the bis-(4-methylbenzoxazol-2-yl)-methanide ligand. Dalton Transactions (Cambridge, England: 2003), 45(14), 6149–6158. https://doi.org/https://doi.org/10.1039/C5DT03913D
- Dauer, D. R., Koehne, I., Herbst‐Irmer, R., & Stalke, D. (2017). From Bis (imidazol‐2‐yl) methanes to asymmetrically substituted bis (heterocyclo) methanides in metal coordination. European Journal of Inorganic Chemistry, 2017(13), 1966–1978. https://doi.org/https://doi.org/10.1002/ejic.201601470
- Dubey, R., Shrivastava, P. K., Basniwal, P. K., Bhattacharya, S., Moorthy, N., & Narayana, S. H. (2006). 2-(4-aminophenyl) benzothiazole: A potent and selective pharmacophore with novel mechanistic action towards various tumour cell lines. Mini Reviews in Medicinal Chemistry, 6(6), 633–637. https://doi.org/https://doi.org/10.2174/138955706777435706
- Elagab, H. A., & Alt, H. G. (2015). Structure–property-relationship studies with ethylene polymerization catalysts of Ti, Zr and V containing heterocyclic ligands. Inorganica Chimica Acta, 437, 26–35. https://doi.org/https://doi.org/10.1016/j.ica.2015.08.002
- Erol, M., Celik, I., Temiz-Arpaci, O., Kaynak-Onurdag, F., & Okten, S. (2020). Design, synthesis, molecular docking, density functional theory and antimicrobial studies of some novel benzoxazole derivatives as structural bioisosteres of nucleotides. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1760134
- Han, X., Shen, K., Huang, G., Li, C., Mao, S., Shi, X., & Wu, H. (2018). Synthesis, structure, electrochemical properties and superoxide radical scavenging activities of two thiocyanate copper (II) complexes with different pyridyl-benzoxazole ligands. Journal of Molecular Structure, 1169, 18–24. https://doi.org/https://doi.org/10.1016/j.molstruc.2018.05.058
- Himmetoglu, S., Dincer, Y., Ersoy, Y. E., Bayraktar, B., Celik, V., & Akçay, T. (2009). DNA oxidation and antioxidant status in breast cancer. Journal of Investigative Medicine, 57(6), 720–723. https://doi.org/https://doi.org/10.2310/JIM.0b013e3181adfb5b
- Jenkins, T. C. (2000). G-quadruplex DNA: a target for drug design. Current Medicinal Chemistry, 7, 99–115. https://doi.org/https://doi.org/10.2174/0929867003375551
- Kretsch, J., Koehne, I., Lõkov, M., Leito, I., & Stalke, D. (2019). Bis (benzoxazol‐2‐yl) methanes Hounding NacNac: Varieties and Applications in Main Group Metal Coordination. European Journal of Inorganic Chemistry, 2019(28), 3258–3264. https://doi.org/https://doi.org/10.1002/ejic.201900631
- Li, Y., Qian, F., Ge, X., Liu, T., Jalani, H. B., Lu, H., & Li, G. (2019). Copper and cobalt co-catalyzed aerobic oxidative cross-dehydrogenative coupling reaction of (benzo) azoles. Green Chemistry, 21(21), 5797–5802. https://doi.org/https://doi.org/10.1039/C9GC02464F
- Liu, Q.-Q., Lu, K., Zhu, H.-M., Kong, S.-L., Yuan, J.-M., Zhang, G.-H., Chen, N.-Y., Gu, C.-X., Pan, C.-X., Mo, D.-L., & Su, G.-F. (2019). Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo. European Journal of Medicinal Chemistry, 165, 293–308. https://doi.org/https://doi.org/10.1016/j.ejmech.2019.01.004
- Mabkhot, Y. N., Barakat, A., Al-Majid, A. M., Alshahrani, S., Yousuf, S., & Choudhary, M. I. (2013). Synthesis, reactions and biological activity of some new bis-heterocyclic ring compounds containing sulphur atom. Chemistry Central Journal, 7(1), 112 https://doi.org/https://doi.org/10.1186/1752-153X-7-112
- Madia, V. N., Messore, A., Pescatori, L., Saccoliti, F., Tudino, V., De Leo, A., Bortolami, M., Scipione, L., Costi, R., Rivara, S., Scalvini, L., Mor, M., Ferrara, F. F., Pavoni, E., Roscilli, G., Cassinelli, G., Milazzo, F. M., Battistuzzi, G., Di Santo, R., & Giannini, G. (2018). Novel benzazole derivatives endowed with potent antiheparanase activity. Journal of Medicinal Chemistry, 61(15), 6918–6936. https://doi.org/https://doi.org/10.1021/acs.jmedchem.8b00908
- Matthews, C. J., Leese, T. A., Clegg, W., Elsegood, M. R., Horsburgh, L., & Lockhart, J. C. (1996). A route to bis (benzimidazole) ligands with built-in asymmetry: Potential models of protein binding sites having histidines of different basicity. Inorganic Chemistry, 35(26), 7563–7571. https://doi.org/https://doi.org/10.1021/ic960777m
- Monguchi, D., Yamamura, A., Fujiwara, T., Somete, T., & Mori, A. (2010). Oxidative dimerization of azoles via copper (II)/silver (I)-catalyzed CH homocoupling. Tetrahedron Letters, 51(5), 850–852. https://doi.org/https://doi.org/10.1016/j.tetlet.2009.12.016
- Mosdam, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assay. Journal of Immunological Methods, 65, 55–63. https://doi.org/https://doi.org/10.1016/0022-1759(83)90303-4
- Nasr-Esfahani, M., Mohammadpoor-Baltork, I., Khosropour, A. R., Moghadam, M., Mirkhani, V., & Tangestaninejad, S. (2013). Synthesis and characterization of Cu (II) containing nanosilica triazine dendrimer: A recyclable nanocomposite material for the synthesis of benzimidazoles, benzothiazoles, bis-benzimidazoles and bis-benzothiazoles. Journal of Molecular Catalysis A: Chemical, 379, 243–254. https://doi.org/https://doi.org/10.1016/j.molcata.2013.08.009
- Noel, S., Cadet, S., Gras, E., & Hureau, C. (2013). The benzazole scaffold: A SWAT to combat Alzheimer's disease. Chemical Society Reviews, 42(19), 7747–7762. https://doi.org/https://doi.org/10.1039/C3CS60086F
- Peng, C. C., Zhang, M. J., Sun, X. X., Cai, X. J., Chen, Y., & Chen, W. H. (2016). Highly efficient anion transport mediated by 1,3-bis(benzimidazol-2-yl)benzene derivatives bearing electron-withdrawing substituents. Organic & Biomolecular Chemistry, 14(35), 8232–8236. https://doi.org/https://doi.org/10.1039/C6OB01461E
- Racané, L., Pavelić, S. K., Ratkaj, I., Stepanić, V., Pavelić, K., Tralić-Kulenović, V., & Karminski-Zamola, G. (2012). Synthesis and antiproliferative evaluation of some new amidino-substituted bis-benzothiazolyl-pyridines and pyrazine. European Journal of Medicinal Chemistry, 55, 108–116. https://doi.org/https://doi.org/10.1016/j.ejmech.2012.07.005
- Reddy, G. M., Garcia, J. R., Reddy, V. H., Andrade, A. M., Camilo, A., Jr. Ribeiro, R. A. P., & Lazaro, S. R. (2016). Synthesis, antimicrobial activity and advances in structure-activity relationships (SARs) of novel tri-substituted thiazole derivatives. European Journal of Medicinal Chemistry, 123, 508–513. https://doi.org/https://doi.org/10.1016/j.ejmech.2016.07.062
- Sato, S., Kajiura, T., Noguchi, M., Takehana, K., Kobayashi, T., & Tsuji, T. (2001). AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp. The Journal of Antibiotics, 54(1), 102–104. https://doi.org/https://doi.org/10.7164/antibiotics.54.102
- Sepehri, S., Soleymani, S., Zabihollahi, R., Aghasadeghi, M. R., Sadat, M., Saghaie, L., & Fassihi, A. (2017). Synthesis, biological evaluation, and molecular docking studies of novel 4‐[4‐arylpyridin‐1 (4H)‐yl] benzoic acid derivatives as anti‐HIV‐1 agents. Chemistry & Biodiversity, 14(12), e1700295. https://doi.org/https://doi.org/10.1002/cbdv.201700295
- Shaker, R. M. (1999). One-pot synthesis of novel 1, 1′-and 1, 4-bridged bis-thiazolidinone derivatives and their antimicrobial activity. Phosphorus, Sulfur, and Silicon and the Related Elements, 149(1), 7–14. https://doi.org/https://doi.org/10.1080/10426509908037017
- Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer Society, 2019. CA: A Cancer Journal for Clinicians, 69(1), 7–34. https://doi.org/https://doi.org/10.3322/caac.21551
- Singh, M. P., Joseph, T., Kumar, S., Bathini, Y., & Lown, J. W. (1992). Synthesis and sequence-specific DNA binding of a topoisomerase inhibitory analog of Hoechst 33258 designed for altered base and sequence recognition. Chemical Research in Toxicology, 5(5), 597–607. https://doi.org/https://doi.org/10.1021/tx00029a003
- Sun, J., Yuan, B., Hou, X., Yan, C., Sun, X., Xie, Z., Shao, X., & Zhou, S. (2018). Broadband optical limiting of a novel twisted tetrathiafulvalene incorporated donor–acceptor material and its ormosil gel glasses. Journal of Materials Chemistry C, 6(31), 8495–8501. https://doi.org/https://doi.org/10.1039/C8TC02364F
- Thurston, D. E., Bose, D. S., Thompson, A. S., Howard, P. W., Leoni, A., Croker, S. J., Jenkins, T. C., Neidle, S., Hartley, J. A., & Hurley, L. H. (1996). Synthesis of sequence-selective C8-linked pyrrolo[2,1-c][1,4]benzodiazepine DNA interstrand cross-linking agents. The Journal of Organic Chemistry, 61(23), 8141–8147. https://doi.org/https://doi.org/10.1021/jo951631s
- Ueki, M., Ueno, K., Miyadoh, S., Abe, K., Shibata, K., Taniguchi, M., & Oi, S. (1993). UK-1, a novel cytotoxic metabolite from Streptomyces sp. 517-02. The Journal of Antibiotics, 46(7), 1089–1094. https://doi.org/https://doi.org/10.7164/antibiotics.46.1089
- White, A. W., Curtin, N. J., Eastman, B. W., Golding, B. T., Hostomsky, Z., Kyle, S., Li, J., Maegley, K. A., Skalitzky, D. J., Webber, S. E., Yu, X.-H., & Griffin, R. J. (2004). Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors. Bioorganic & Medicinal Chemistry Letters, 14(10), 2433–2437. https://doi.org/https://doi.org/10.1016/j.bmcl.2004.03.017
- Wu, Q., Chen, Y., Yan, D., Zhang, M., Lu, Y., Sun, W. Y., & Zhao, J. (2017). Unified synthesis of mono/bis-arylated phenols via RhIII-catalyzed dehydrogenative coupling. Chemical Science, 8(1), 169–173. https://doi.org/https://doi.org/10.1039/C6SC03169B